Brief: Kiora Pharmaceuticals - Enters Exclusive Option Agreement With Senju - SEC Filing
03/06/2025 13:01
June 3 (Reuters) - Kiora Pharmaceuticals Inc KPRX.O: KIORA PHARMACEUTICALS INC - ENTERS EXCLUSIVE OPTION AGREEMENT WITH SENJU - SEC FILING KIORA PHARMACEUTICALS INC - SENJU TO PAY KIORA $1.25 MILLION IMMEDIATE OPTION PAYMENT - SEC FILING KIORA PHARMACEUTICALS INC - TOTAL DEAL VALUE ABOUT $110 MILLION PLUS ROYALTIES Source text: [ID:n0001372514-25-000050] Further company coverage: KPRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing